MI HB4815

Requires Michigan's Medicaid medical assistance program to cover all medically necessary care and treatment for menopause and perimenopause, including hormone replacement therapy and FDA-approved treatments

Prohibits prior authorization requirements for any prescription medications used to treat menopause and perimenopause symptoms under Medicaid

Bans step therapy or "fail-first" policies for hormone replacement therapy prescribed to treat menopause and perimenopause symptoms

Adds menopause and perimenopause treatments to the existing list of prescription drug categories exempt from prior authorization, which includes mental health medications, HIV treatments, cancer drugs, and organ replacement therapy

Defines menopause as permanent cessation of menstruation due to loss of ovarian function, and perimenopause as the transition period near the end of reproductive years